Nationwide Fund Advisors’s Alder Biopharmaceuticals, Inc. ALDR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-32,480
| Closed | -$398K | – | 2765 |
|
|
2017
Q3 | $398K | Sell |
32,480
-25,657
| -44% | -$314K | ﹤0.01% | 2294 |
|
|
2017
Q2 | $666K | Buy |
58,137
+11,853
| +26% | +$136K | ﹤0.01% | 2025 |
|
|
2017
Q1 | $963K | Sell |
46,284
-1,937
| -4% | -$40.3K | ﹤0.01% | 1766 |
|
|
2016
Q4 | $1M | Sell |
48,221
-1,478
| -3% | -$30.7K | ﹤0.01% | 1782 |
|
|
2016
Q3 | $1.63M | Hold |
49,699
| – | – | 0.01% | 1492 |
|
|
2016
Q2 | $1.24M | Buy |
49,699
+16,126
| +48% | +$403K | 0.01% | 1604 |
|
|
2016
Q1 | $834K | Buy |
33,573
+3,193
| +11% | +$79.3K | ﹤0.01% | 1819 |
|
|
2015
Q4 | $1M | Buy |
30,380
+15,457
| +104% | +$510K | ﹤0.01% | 1734 |
|
|
2015
Q3 | $489K | Buy |
14,923
+1,584
| +12% | +$51.9K | ﹤0.01% | 2133 |
|
|
2015
Q2 | $707K | Buy |
13,339
+5,926
| +80% | +$314K | ﹤0.01% | 2052 |
|
|
2015
Q1 | $214K | Buy |
7,413
+1,204
| +19% | +$34.8K | ﹤0.01% | 2657 |
|
|
2014
Q4 | $181K | Hold |
6,209
| – | – | ﹤0.01% | 2682 |
|
|
2014
Q3 | $79K | Buy |
6,209
+130
| +2% | +$1.65K | ﹤0.01% | 3044 |
|
|
2014
Q2 | $122K | Buy |
+6,079
| New | +$122K | ﹤0.01% | 2963 |
|